BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24675887)

  • 1. Promyelocytic leukemia bodies tether to early endosomes during mitosis.
    Palibrk V; Lång E; Lång A; Schink KO; Rowe AD; Bøe SO
    Cell Cycle; 2014; 13(11):1749-55. PubMed ID: 24675887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1.
    Dellaire G; Eskiw CH; Dehghani H; Ching RW; Bazett-Jones DP
    J Cell Sci; 2006 Mar; 119(Pt 6):1034-42. PubMed ID: 16492707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
    Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
    J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PML Bodies in Mitosis.
    Lång A; Lång E; Bøe SO
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
    Condemine W; Takahashi Y; Le Bras M; de Thé H
    J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
    Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
    J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.
    Pennella MA; Liu Y; Woo JL; Kim CA; Berk AJ
    J Virol; 2010 Dec; 84(23):12210-25. PubMed ID: 20861261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein.
    Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
    BMC Mol Biol; 2010 Nov; 11():89. PubMed ID: 21092142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35.
    Salsman J; Wang X; Frappier L
    Virology; 2011 Jun; 414(2):119-29. PubMed ID: 21489587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein.
    Daniels MJ; Marson A; Venkitaraman AR
    Nat Struct Mol Biol; 2004 Nov; 11(11):1114-21. PubMed ID: 15467728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The number of PML nuclear bodies increases in early S phase by a fission mechanism.
    Dellaire G; Ching RW; Dehghani H; Ren Y; Bazett-Jones DP
    J Cell Sci; 2006 Mar; 119(Pt 6):1026-33. PubMed ID: 16492708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
    Reineke EL; Kao HY
    Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
    Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
    PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The arsenic-based cure of acute promyelocytic leukemia promotes cytoplasmic sequestration of PML and PML/RARA through inhibition of PML body recycling.
    Lång E; Grudic A; Pankiv S; Bruserud O; Simonsen A; Bjerkvig R; Bjørås M; Bøe SO
    Blood; 2012 Jul; 120(4):847-57. PubMed ID: 22692509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional organization of promyelocytic leukemia nuclear bodies.
    Lang M; Jegou T; Chung I; Richter K; Münch S; Udvarhelyi A; Cremer C; Hemmerich P; Engelhardt J; Hell SW; Rippe K
    J Cell Sci; 2010 Feb; 123(Pt 3):392-400. PubMed ID: 20130140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of component exchange at PML nuclear bodies.
    Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
    J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis.
    Chen YC; Kappel C; Beaudouin J; Eils R; Spector DL
    Mol Biol Cell; 2008 Jul; 19(7):3147-62. PubMed ID: 18480407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.